The Venture Codex Logo

The Venture Codex

Overview

Healthcare company focused on pharmaceuticals.

Deals · 12mo

1

Stage focus

Series A

Geographic focus

Australia

Sector focus

—

Investment portfolio

2rounds
NAMEDATESIZE
Ferronova
Dec 2025Led
$6 MSeries A
Ferronova
Jan 2023Led
$8 MOther Equity
Ferronova
Dec 2025Led
$6 MSeries A
Ferronova
Jan 2023Led
$8 MOther Equity
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Renew Pharmaceuticals: 2 funding rounds are recorded in the selected participation categories.All available history.
Renew Pharmaceuticals: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A10
Other Equity10

Monthly Deal Activity

Renew Pharmaceuticals: 2 deals are recorded across 46 months.All available history.
Renew Pharmaceuticals: 2 deals are recorded across 46 months. All available history
MonthDeals
Jan '231
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '251
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Renew Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Renew Pharmaceuticals: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

Renew Pharmaceuticals: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Renew Pharmaceuticals: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M2
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Renew Pharmaceuticals: Australia has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Renew Pharmaceuticals: Australia has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
Australia2
Renew Pharmaceuticals: 4 co-investors are shown, with Artesian sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Renew Pharmaceuticals: 4 co-investors are shown, with Artesian sharing 2 recorded deals. All available history
Co-investorShared deals
Artesian2
Uniseed2
Australian Government1
South Australian Venture Capital Fund1

Investment Strategy

Renew Pharmaceuticals: Led accounts for 100% and participating for 0% of round participation.All available history.
Renew Pharmaceuticals: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led2100%
Participating00%
Renew Pharmaceuticals: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Renew Pharmaceuticals: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead150%
Co-led150%

Team

Declan Cassells

Chief Operating Officer